Press Releases

Investor Resources
Contact Us
Investor ResourcesPress Releases

Press Releases

Cardiol Therapeutics Closes $1,500,000 Non-Brokered Private Placement


March 24, 2017

Cardiol Therapeutics Appoints Afsaneh Lavasanifar, PharmD, PhD to Scientific Advisory Board


March 14, 2017

Cardiol Therapeutics Granted Exclusive Global License to Nanotechnology for Heart Failure, Cardiovascular, and Cardiopulmonary Disease


January 20, 2017

2025 Cardiol Therapeutics. All right reserved.